Independent fund research. Built on SEC filings.

How we research funds

ETF overlap

GDOC vs ETHSX overlap: 51% of top holdings shared

Bottom line

How much do GDOC and ETHSX overlap?

51% of their top holdings overlap by weight. 12 securities appear in both funds' top 25, making up 56.0% of GDOC's assets and 47.6% of ETHSX's. They share a meaningful core but differ in the rest of the portfolio.

Updated Nov 22, 2026

Overlap at a glance

GDOCETHSX
Weight overlap (top 25)51%
Shared holdings12
Weight in shared holdings56.0%47.6%
Total positions4242
Expense ratio0.75%1.18%
Holdings as ofMay 31, 2026May 31, 2026

Source: SEC Form N-PORT (periods May 31, 2026 / May 31, 2026)

Holdings GDOC and ETHSX have in common

Holding% of GDOC% of ETHSXOverlap
Eli Lilly & Company LLY13.28%12.47%12.47%
Johnson & Johnson JNJ8.07%6.45%6.45%
Merck & Company Inc MRK5.94%5.08%5.08%
Astrazeneca Plc AZN4.84%6.24%4.84%
Thermo Fisher Scientific Inc TMO4.52%2.79%2.79%
Argenx Se ARGX4.07%1.61%1.61%
Intuitive Surgical Inc ISRG3.90%2.72%2.72%
Boston Scientific Corp BSX3.78%2.18%2.18%
Lonza Group Ag LONN2.80%1.77%1.77%
Royalty Pharma Plc RPRX1.77%1.58%1.58%
Mettler-toledo International Inc MTD1.59%1.36%1.36%
Vertex Pharmaceuticals Inc VRTX1.48%3.38%1.48%

Source: SEC Form N-PORT (periods May 31, 2026 / May 31, 2026)

Free weekly newsletter

The Fund Letter

Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.

Free. Unsubscribe anytime. We never sell your email.

What each fund holds that the other doesn't

Top-25 holdings that appear in only one of the two funds' top 25.

Only in GDOC

  1. Guardant Health Inc — 5.34%
  2. Hoya Corp — 3.53%
  3. Edwards Lifesciences Corp — 2.98%
  4. Dexcom Inc — 2.79%
  5. Agilent Technologies Inc — 2.77%
  6. Roivant Sciences Ltd — 2.39%
  7. Cencora Inc — 2.34%
  8. Apogee Therapeutics Inc — 1.97%
  9. Penumbra Inc — 1.61%
  10. Goldman Sachs Trust — 1.43%
  11. Cytokinetics Inc — 1.40%
  12. Ionis Pharmaceuticals Inc — 1.37%
  13. Xenon Pharmaceuticals Inc — 1.35%

Only in ETHSX

  1. AbbVie Inc — 6.46%
  2. UnitedHealth Group Inc — 5.49%
  3. Roche Holding AG — 5.44%
  4. Bristol-Myers Squibb Co — 4.25%
  5. Gilead Sciences Inc — 3.34%
  6. Sanofi SA — 2.95%
  7. Stryker Corp — 2.21%
  8. Medtronic PLC — 1.80%
  9. Novo Nordisk A/S — 1.71%
  10. Abbott Laboratories — 1.65%
  11. Novartis AG — 1.65%
  12. Neurocrine Biosciences Inc — 1.41%
  13. Straumann Holding AG — 1.34%

Asset mix

Asset typeGDOCETHSX
Stocks98.5%99.4%
Cash & short-term funds1.4%0.3%

Source: SEC Form N-PORT (periods May 31, 2026 / May 31, 2026)

Country mix

CountryGDOCETHSX
US76.3%69.4%
CH3.9%10.2%
GB6.6%7.8%
NL4.1%2.0%
JP3.5%—
FR0.6%3.2%
DK—2.9%
BM2.4%—

Source: SEC Form N-PORT (periods May 31, 2026 / May 31, 2026)

Check another pair

FAQ

How much do GDOC and ETHSX overlap?
About 51% by weight. 12 securities appear in both funds' top 25 holdings; they make up 56.0% of GDOC's assets and 47.6% of ETHSX's. They share a meaningful core but differ in the rest of the portfolio.
What stocks do GDOC and ETHSX have in common?
The largest shared holdings are Eli Lilly & Company, Johnson & Johnson, Merck & Company Inc, Astrazeneca Plc, Thermo Fisher Scientific Inc.
Should I own both GDOC and ETHSX?
They overlap in part. Owning both concentrates you in the shared names; check that the combined weight in those stocks is what you intend.

Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.